Does FUTIBATINIB Cause Hyperphosphataemia? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hyperphosphataemia have been filed in association with FUTIBATINIB (LYTGOBI). This represents 13.7% of all adverse event reports for FUTIBATINIB.
22
Reports of Hyperphosphataemia with FUTIBATINIB
13.7%
of all FUTIBATINIB reports
6
Deaths
6
Hospitalizations
How Dangerous Is Hyperphosphataemia From FUTIBATINIB?
Of the 22 reports, 6 (27.3%) resulted in death, 6 (27.3%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUTIBATINIB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does FUTIBATINIB Cause?
Death (30)
Diarrhoea (29)
Nausea (21)
Disease progression (20)
Dry mouth (18)
Fatigue (18)
Off label use (16)
Vomiting (15)
Dry eye (13)
Constipation (12)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which FUTIBATINIB Alternatives Have Lower Hyperphosphataemia Risk?
FUTIBATINIB vs GABAPENTIN
FUTIBATINIB vs GABAPENTIN ENACARBIL
FUTIBATINIB vs GADAVIST
FUTIBATINIB vs GADOBENATE DIMEGLUMINE
FUTIBATINIB vs GADOBUTROL